Episodes
Wednesday Dec 07, 2016
Preventing Pediatric Dosing Errors – Is It Time to Dump the Medicine Cup?
Wednesday Dec 07, 2016
Wednesday Dec 07, 2016
Children are often given liquid dosage forms for both prescription and over-the-counter medicines. Several studies have shown that caregivers unintentionally put children at risk by inaccurately measuring the dose of liquid medications. In 2015, the American Academy of Pediatrics (AAP) adopted a policy statement which recommends exclusively using milliliters for dosing instructions to prevent dosing errors. Our guest today critically examines a recent study that examined labeling and dosing tools that may contribute to medication errors.
Thursday Dec 01, 2016
Pharmacists Patient Care Process
Thursday Dec 01, 2016
Thursday Dec 01, 2016
Our guest, Dr. Melissa Somma McGivney, describes the Pharmacists Patient Care Process and explains why having a consistent philosophy of practice, a consistent process of care, and a sustainable practice management system are critical for success.
Friday Oct 21, 2016
Opioid Safety and Overdose Prevention
Friday Oct 21, 2016
Friday Oct 21, 2016
While narcotic analgesics remain a mainstay for the treatment of acute and chronic pain, urgent care visits and deaths from opioid overdoses have skyrocketed. Our panelists are Dr. Lucas Hill from the University of Texas at Austin and Jeffrey Bratberg from the University of Rhode Island. Dr. Hill practices in a primary care setting and maintains the iForumRx Opioid Safety and Overdose Prevention Resource Page. Dr. Bratberg helped develop, implement, and expand the Collaborative Pharmacy Practice for Naloxone Partnership in Rhode Island. Drs. Hill and Bratberg describe how healthprofessionals - particularly ambulatory care pharmacists - can take action to improve the safe use of opioids and prevent overdoses.
Thursday Sep 29, 2016
Eleven Things Every Clinician Should Know About the “Egregious Eleven”
Thursday Sep 29, 2016
Thursday Sep 29, 2016
A recent paper published in Diabetes Care proposing a new classification system for diabetes challenges our existing paradigm and has significant implications for our treatment approach for diabetes.
Friday Jul 15, 2016
Preventing Weight Gain - Recommending Behavior Change in Young Adults
Friday Jul 15, 2016
Friday Jul 15, 2016
We're all aware that there is an obesity epidemic and its linked to dozens of health problems. But nothing we've done so far — public awareness campaigns, changes in school lunch programs, and approving new drugs for weight loss — has halted this epidemic. The prevalence of obesity continues to climb in young adults and most of us keep packing on the pounds as we get older! Thus preventing weight gain in young adults is critically important to long-term outcomes. The recent results of the Study of Novel Approaches to Weight Gain Prevention (SNAP) provides evidence to guide recommendations for behavioral change.
Friday Mar 25, 2016
Crossing the Periprocedural Bridge in Patients with Atrial Fibrillation
Friday Mar 25, 2016
Friday Mar 25, 2016
For over two decades LMWHs have been routinely used to provide therapeutic coverage in patients who must temporarily stop warfarin. Current guidelines suggest using injectable anticoagulants during warfarin interruption (aka bridging) in patients with atrial fibrillation based on patients’ risk of arterial thrombosis. Using the CHADS2 score to assess risk, the guidelines recommend (grade 2C) bridge therapy if the CHADS2 score is 5 or higher and not bridging if the CHADS2 score is 2 or lower. But what about patients with a CHADS2 score of 3 or 4?
Friday Mar 11, 2016
Reconsidering Strategies for Insulin Intensification
Friday Mar 11, 2016
Friday Mar 11, 2016
Basal, prandial, NPH, ultra-long, inhaled, 70/30, 75/25, 50/50, U-100, U-200, U-300, and U-500 insulin … the list of options for patients with diabetes requiring insulin continues to expand. Current guidelines for glycemic management of patients with type 2 diabetes provide specific recommendations for the initiation of insulin therapy, but not insulin intensification. The recently published LanScape study provides a foundation for making evidence-based clinical decisions.
Friday Feb 26, 2016
TEXT ME — Text Messaging to Promote Behavior Change
Friday Feb 26, 2016
Friday Feb 26, 2016
Wednesday Feb 10, 2016
Pulling Ahead After a SPRINT – Evidence for Lower Blood Pressure Goals
Wednesday Feb 10, 2016
Wednesday Feb 10, 2016
The debate over the intensity of blood pressure (BP) lowering for patients with hypertension has been going on for decades. Additional fuel to the fire was recently added with the early halt and publication of the Systolic Blood Pressure Intervention Trial (SPRINT). So “how low should you go” for patients with high BP? Do lower BP goals reduce CV outcomes and death, particularly in patients at high risk? Do they cause greater adverse effects? Or perhaps even worsen CV outcomes? These questions were examined in SPRINT.
Friday Oct 16, 2015
How Long Is Long Enough? Extending OAC After Unprovoked PE
Friday Oct 16, 2015
Friday Oct 16, 2015
The recommended treatment duration for a first episode of unprovoked venous thromboembolism (VTE) is, at a minimum, 3 months with extended anticoagulation favored for those who are not at high risk for bleeding. However, the optimal duration of anticoagulation therapy remains unknown. The Prolonged Anticoagulation Treatment for a First Episode of Idiopathic Pulmonary Embolism (PADIS-PE) study examines this question but, most importantly, provides insights about patient outcomes after anticoagulation treatment is discontinued